Skip to main content
SpringerLink
Log in

Pure red cell aplasia: Review of treatment and proposal for a treatment strategy

  • Leading article
  • Published:
Blut Aims and scope Submit manuscript

Summary

The management of pure red cell aplasia (PRCA) continues to challenge clinical investigators because the pathophysiology is heterogeneous and poorly understood. There are five treatment regimens that have established efficacy for patients with chronic PRCA. In patients with congenital hypoplastic anemia the best results have been reported using corticosteroids. Cyclosporine A is recommended as the treatment of choice in acquired PRCA. High-dose intravenous immunoglobulin therapy is highly effective in PRCA associated with parvovirus B19 infections and impaired IgG-antibody response. Treatment failures may be successfully managed with horse anti-human thymocyte globulin or cyclophosphamide plus corticosteroids. The potential of hematopoietic growth factors in the treatment of PRCA awaits further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abkowitz J, Powell JS, Nakamura JM, Kadin M, Adamson JW (1986) Pure red cell aplasia: Response to therapy with antithymocyte globulin. Am J Hematol 23: 363–371

    Google Scholar 

  2. Belloy M, Morinet F, Blondin G, Courouce AM, Peyrol Y, Vilmer E (1990) Erythroid hypoplasia due to chronic infection with parvovirus B19. N Engl J Med 322: 633–642

    Google Scholar 

  3. Berkman SA, Lee ML, Gale RP (1988) Clinical use of intravenous immunoglobulins. Semin Hematol 25: 140–158

    Google Scholar 

  4. Berlin G, Liedén G (1986) Long-term remission of pure red cell aplasia after plasma exchange and lymphocytopheresis. Scand J Haematol 36: 121–122

    Google Scholar 

  5. Bierloy L, Wright R, Nienhuis AW, Young NS, Kaliner MA (1988) Antithymocyte globulin hypersensitivity in bone marrow failure patients. JAMA 260: 3164–3167

    Google Scholar 

  6. Chikkappa G, Pasquale D, Phillips PG, Mangan KF, Tsau MF (1987) Cyclosporine A for the treatment of pure red cell aplasia in a patient with chronic lymphocytic leukemia. Am J Hematol 26: 179–189

    Google Scholar 

  7. Chikkappa G, Zarrabi MH, Tran MF (1986) Pure red cell aplasia in patients with chronic lymphocytic leukemia. Medicine 65: 339–351

    Google Scholar 

  8. Christen R, Morant R, Fehr J (1989) Cyclosporin A therapy of pure red cell aplasia in a patient with B-cell chronic lymphocytic leukemia. Eur J Haematol 42: 303–307

    Google Scholar 

  9. Clark DA, Dessypris EN, Krantz SB (1984) Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 63: 277–280

    Google Scholar 

  10. Clauvel JP, Vainchenker W, Herrera A, Dellagik, Vinci G, Tabilio A, Lacombe C (1983) Treatment of pure red cell aplasia by high dose intravenous immunoglobulins. Br J Haematol 55: 380–382

    Google Scholar 

  11. Debusscher L, Paridaens R, Stryckmans P (1985) Cyclosporine for pure red cell aplasia. Blood 65: 249

    Google Scholar 

  12. Dessypris EN (1988) Pure red cell aplasia. The Johns Hopkins University Press, Baltimore

    Google Scholar 

  13. Diamond LK, Wang WC, Alter BP (1976) Congenital hypoplastic anemia. In: Schulman I (ed) Advances in pediatrics, vol 22. Year Book Medical Publishers, Chicago, pp 349–378

    Google Scholar 

  14. Finlay JL, Toretsky J, Hoffman R, Bruno E, Shakidi NT (1984) Cyclosporine A in refractory aplastic anemia. Blood 64 [Suppl 1]: 104a (abstr)

  15. Firkin TC, Maker D (1988) Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasia. Eur J Haematol 41: 212–217

    Google Scholar 

  16. Frickhofen N, Abkowitz J, King L, Astrow A, Halperin I, Young N (1989) Red cell aplasia due to persistent B19 parvovirus infection in HIV-infected patients and its treatment with immunoglobulin. Blood 74 [Suppl 1]: 44a (abstr)

  17. Gratwohl A, Speck B, Osterwalder M, Corneo M, Nissen C (1983) Behandlung der Erythroaplasie (pure red cell aplasia) mit Antilymphozytenglobulin und kurzfristig hochdosiertem Prednison. Schweiz Med Wochenschr 113: 1480 (abstr)

    Google Scholar 

  18. Hagberg H, Nilsson P, Nisell J (1980) Treatment of pure red cell anemia with antilymphocyte globulin. Report of two cases. Scand J Haematol 24: 360–364

    Google Scholar 

  19. Halperin DS, Estrov Z, Freedman MH (1989) Diamond-Blackfan anemia: promotion of marrow erythropoiesis in vitro by recombinant interleukin-3. Blood 73: 1168–1174

    Google Scholar 

  20. Harris K, Kitamura T, Jacobs H, Winkelmann JC (1989) Pure red cell aplasia associated with an autoantibody specific for a membrane protein on red cell precursors. Blood 74 [Suppl 1]: 102a (abstr)

  21. Hinterberger-Fischer M, Höcker P, Lechner K, Seewann H, Hinterberger W (1989) Oral cyclosporin A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure. Eur J Haematol 43: 136–142

    Google Scholar 

  22. Jacobs P, Wood L (1988) Pure red cell aplasia. Stable complete remission following antilymphocyte globulin administration. Eur J Haematol 40: 371–374

    Google Scholar 

  23. Kahan BD (1989) Drug therapy: cyclosporine. N Engl J Med 321: 1725–1738

    Google Scholar 

  24. Khelif A, Vau HV, Tremisi JP, Alfons F, Perrot D, Motin J, Viala JJ (1985) Remission of pure red cell aplasia following plasma exchange. Scand J Haematol 34: 13–15

    Google Scholar 

  25. Krantz SB (1972) Studies on pure red cell aplasia. III. Treatment with horse antihuman thymocyte gammaglobulin. Blood 39: 347–360

    Google Scholar 

  26. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS (1989) Pure red cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 321: 519–523

    Google Scholar 

  27. Lacombe C, Casadevall N, Muller O, Varet B (1984) Erythroid progenitors in adult chronic pure red cell aplasia: Relationship of in vitro erythroid colonies to therapeutic response. Blood 64: 71–77

    Google Scholar 

  28. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS (1989) Cyclosporine therapy of aplastic anemia, congenital and acquired red cell aplasia. Br J Haematol 72: 278–284

    Google Scholar 

  29. Mangan K, Shadduck RK (1984) Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: Correlation with in vitro erythroid culture studies. Am J Hematol 17: 417–426

    Google Scholar 

  30. Marimone G, Mombelloni P, Marini G, Ghio R, Roucoli B, Rossi G, Verzura P, Protto C (1981) Bone marrow erythroblastic recovery after plasmapheresis in acquired pure red cell aplasia. Haematologica 66: 796–802

    Google Scholar 

  31. Marmont A (1984) Is antilymphocytic globulin a better immunosuppressant than cyclophosphamide for pure red cell aplasia? Br J Haematol 56: 680–681

    Google Scholar 

  32. Marmont A, Peschle C, Sanguineti M, Condorelli M (1975) Pure red cell aplasia: response of three patients to cyclophosphamide and/or antilymphocyte globulin and demonstration of two types of serum IgG inhibitors to erythropoiesis. Blood 45: 247–261

    Google Scholar 

  33. McGuirre WA, Yank HH, Bruno E, Brandt J, Briddell R, Coates TD, Hoffman R (1987) Treatment of antibody-mediated pure red cell aplasia with high-dose intravenous gammaglobulin. N Engl J Med 317: 1004–1008

    Google Scholar 

  34. Means RT, Olsen NJ, Krantz SB, Graber SE, Dessypris EN, Stone WJ, Pincus TP, O'Neil V (1987) Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro results. Blood 70 [Suppl 1): 139 (abstr)

    Google Scholar 

  35. Messner HA, Fauser AA, Curtis JE, Ootten D (1981) Control of antibody-mediated pure red cell aplasia by plasmapheresis. N Engl J Med 304: 1334–1338

    Google Scholar 

  36. Mintzer D, Reilly R (1987) Pure red cell aplasia associated with human immunodeficiency virus infection: response to intravenous gammaglobulin. Blood 70 [Suppl 1]: 124a (abstr)

  37. Needleman SW (1989) Durable remission of pure red cell aplasia after treatment with high-dose intravenous gammaglobulin and prednisone. Am J Hematol 32: 150–152

    Google Scholar 

  38. Peschle C, Marmont AM, Marone G, Genovese A, Sasso GF, Condorelli M (1975) Pure red cell aplasia: studies on an IgG serum inhibitor neutralizing erythropoietin. Br J Haematol 30: 411–417

    Google Scholar 

  39. Raghavachar A, Buck C, Heimpel H (1988) Cyclosporin A in B-CLL: Remission of pure red cell aplasia and reduction of the leukemic cell mass (abstr). XXII Congress ISH, abstract book, p 302

  40. Raghavachar A, Heimpel H (1989) Cyclosporine A treatment in seven cases of pure red cell aplasia. Blut 59: 349 (abstr)

    Google Scholar 

  41. Seip M, Vidues J (1985) Cyclosporine A in a case of refractory severe aplastic anemia. Scand J Haematol 34: 228–230

    Google Scholar 

  42. Sieff C (1983) Pure red cell aplasia. Br J Haematol 54: 331–336

    Google Scholar 

  43. Tischler HJ, Leblanc S, Brune H, Welte K, Poliwoda H, Link H (1989) Recombinant human erythropoietin in treatment of pure red cell anemia. Blut 59: 340 (abstr)

    Google Scholar 

  44. Tötterman TH, Höglund M, Bengtsson M, Simonsson B, Almqvist D, Killander A (1989) Treatment of pure red cell aplasia and aplastic anemia with cyclosporin: long-term clinical effects. Eur J Haematol 42: 126–133

    Google Scholar 

  45. Tötterman TH, Nisell J, Killander A, Gahrton G, Lönqvist B (1984) Successful treatment of pure red cell aplasia with cyclosporin. Lancet II: 693

    Google Scholar 

  46. Tsai HP, Arkin S, Lipton JM (1989) An intrinsic progenitor defect in Diamond-Blackfan anemia. Br J Haematol 73: 112–120

    Google Scholar 

  47. Varet B, Picard F, Casadevall N, Dreyfus F, Muller O, Lacombe C (1987) Cyclosporin induced remission in two patients with B-CLL associated PRCA who were resistant to other immunosuppressive drugs. Blood 70 [Suppl 1]: 144a (abstr)

  48. Zaentz SD, Krantz SB, Brown EB (1976) Studies on pure red cell aplasia. VIII. Maintenance therapy with immunosuppressive drugs. Br J Haematol 32: 47–54

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin III, Medizinische Universitätsklinik, Robert-Koch-Strasse 8, D-7900, Ulm, Federal Republic of Germany

    Aruna Raghavachar

Authors
  1. Aruna Raghavachar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raghavachar, A. Pure red cell aplasia: Review of treatment and proposal for a treatment strategy. Blut 61, 47–51 (1990). https://doi.org/10.1007/BF02076698

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02076698

Key words

Search

Navigation